Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Conatus Pharmaceuticals Inc. News

Count your blessings; bet on the banks: rev shark's best blog

Rev Shark steps in for Jim Cramer this week.

Futures point north, Asia mixed despite European attacks

Markets look set to continue their election rally as violence casts a pall over Europe.

Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today

Conatus Pharmaceuticals (CNAT) stock was boosted on Tuesday after Allergan (AGN) agreed to buy Tobira Therapeutics (TBRA) at a 500% premium.

Conatus Pharmaceuticals (CNAT) Stock Surges, Liver Drug Could Treat Zika

Conatus Pharmaceuticals' (CNAT) patented liver drug emricasan has been identified as a promising treatment for the Zika virus.

Conatus Pharmaceuticals (CNAT) Stock Soars on Positive Liver Drug Trial Results

Conatus Pharmaceuticals (CNAT) stock is increasing in mid-morning trading on Wednesday after the company said a Phase 2 trial of its liver drug showed positive results.

Breaking News

Disney Mobile Game Opens Up a New Universe

Familiar Disney characters populate an alternate reality in new interactive game.

Birth Control Stocks May Benefit From the Reversal of Roe v. Wade

The historic Supreme Court decision may force women to make different choices.

Something Strange is Happening With Home Prices

As mortgage rates hit fresh highs, there's something unusual going on with the real estate market.

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.